The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Early Identification of Refractory Epilepsy
Open accessAbstract
BACKGROUND: More than 30 percent of patients with epilepsy have inadequate control of seizures with drug therapy, but why this happens and whether it can be predicted are unknown. We studied the response to antiepileptic drugs in patients with newly diagnosed epilepsy to identify factors associated with subsequent poor control of seizures. METHODS: We prospectively studied 525 patients (age, 9 to 93 years) who were given a diagnosis, treated, and followed up at a single center between 1984 and 1997. Epilepsy was classified as idiopathic (with a presumed genetic basis), symptomatic (resulting from a structural abnormality), or cryptogenic (resulting from an unknown underlying cause). Patients were considered to be seizure-free if they had not had any seizures for at least one year. RESULTS: Among the 525 patients, 333 (63 percent) remained seizure-free during antiepileptic-drug treatment or after treatment was stopped. The prevalence of persistent seizures was higher in patients with symptomatic or cryptogenic epilepsy than in those with idiopathic epilepsy (40 percent vs. 26 percent, P=0.004) and in patients who had had more than 20 seizures before starting treatment than in those who had had fewer (51 percent vs. 29 percent, P<0.001). The seizure-free rate was similar in patients who were treated with a single established drug (67 percent) and patients who were treated with a single new drug (69 percent). Among 470 previously untreated patients, 222 (47 percent) became seizure-free during treatment with their first antiepileptic drug and 67 (14 percent) became seizure-free during treatment with a second or third drug. In 12 patients (3 percent) epilepsy was controlled by treatment with two drugs. Among patients who had no response to the first drug, the percentage who subsequently became seizure-free was smaller (11 percent) when treatment failure was due to lack of efficacy than when it was due to intolerable side effects (41 percent) or an idiosyncratic reaction (55 percent). CONCLUSIONS: Patients who have many seizures before therapy or who have an inadequate response to initial treatment with antiepileptic drugs are likely to have refractory epilepsy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the remaining 30% have drug-resistant epilepsy requiring consideration of surgical intervention, ketogenic dietary therapy, vagus nerve stimulation, or other neuromodulatory approaches6,7”
In the citing paper
“While approximately 70% of patients can achieve seizure freedom with appropriate antiepileptic drug (AED) therapy”
Citations
Cites
Guidelines for Epidemiologic Studies on Epilepsy
(1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb00433.x · Cited by 1,360
Is the underlying cause of epilepsy a major prognostic factor for recurrence?
Semah, F., Picot, M., Adam, C., Broglin, D., Arzimanoglou, A. A., Bazin, B., Cavalcanti, D., & Baulac, M. (1998) · Neurology · doi:10.1212/wnl.51.5.1256 · Cited by 1,105
Engel, J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603073341008 · Cited by 880
Long-Term Prognosis of Seizures with Onset in Childhood
Sillanpää, M. L., Jalava, M., Kaleva, O., & Shinnar, S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806113382402 · Cited by 725
Remission of Seizures and Relapse in Patients with Epilepsy
Annegers, J. F., Hauser, W. A., & Elveback, L. R. (1979) · Epilepsia · doi:10.1111/j.1528-1157.1979.tb04857.x · Cited by 621
Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
Brodie, M. J., UK Lamotrigine/Carbamazepine Monotherapy Trial Group, Richens, A., & Yuen, A. W. C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90581-2 · Cited by 614
Self-citationMDR1 Gene Expression in Brain of Patients with Medically Intractable Epilepsy
Tishler, D. M., Weinberg, K. I., Hinton, D. R., Barbaro, N. M., Annett, G., & Raffel, C. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb01657.x · Cited by 529
Multidrug resistance: molecular mechanisms and clinical relevance
Ling, V. W. T. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051053 · Cited by 525
Brodie, M. J., Overstall, P. W., & Giorgi, L. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(99)00039-x · Cited by 462
Self-citation
Research works printed but not linked: 2
- Dreifuss FE. Classification of epileptic seizures. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Vol. 1. Philadelphia: Lippincott-Raven, 1998:517-24.
- Wolf P. International classification of the epilepsies. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Vol. 1. Philadelphia: Lippincott-Raven, 1998:773-7.
Cited by
Sorted by citations
Items 501–600 of 1,005
Youngerman, B. E., Save, A., & McKhann, G. M. (2019) · Neurosurgery · doi:10.1093/neuros/nyz556 · Cited by 87
Side-effects of antiepileptic drugs: The economic burden
de Kinderen, R. J. A., Evers, S., Rinkens, R., Postulart, D., Vader, C. I., Majoie, M., & Aldenkamp, A. P. (2013) · Seizure · doi:10.1016/j.seizure.2013.11.009 · Cited by 87
Diagnosing and predicting refractory epilepsy
Brodie, M. J. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00507.x · Cited by 87
Self-citationUnited States Epilepsy Center Characteristics
Ostendorf, A. P., Ahrens, S. M., Lado, F. A., Arnold, S. T., Bai, S., Bensalem‐Owen, M., Chapman, K. E., Clarke, D., Eisner, M., Fountain, N. B., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000013130 · Cited by 86
Saito, M., Muñana, K. R., Sharp, N., & Olby, N. J. (2001) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.2001.219.618 · Cited by 86
Anticonvulsant evaluation of clubbed indole-1,2,4-triazine derivatives: A synthetic approach
Ahuja, P., & Siddiqui, N. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.043 · Cited by 86
Melatonin improves sleep in children with epilepsy: a randomized, double-blind, crossover study
Jain, S. V., Horn, P. S., Simakajornboon, N., Beebe, D. W., Holland, K. D., Byars, A. W., & Glauser, T. A. (2015) · Sleep Medicine · doi:10.1016/j.sleep.2015.01.005 · Cited by 87
Measuring the efficacy of antiepileptic drugs
Mohanraj, R., & Brodie, M. J. (2003) · Seizure · doi:10.1016/s1059-1311(03)00047-5 · Cited by 88
Self-citationFinally, a Randomized, Controlled Trial of Epilepsy Surgery
Engel, J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450510 · Cited by 86
Antiepileptic Drug Therapy in Patients with Drug-Resistant Epilepsy
Park, K. M., Kim, S. E., & Lee, B. I. (2019) · Journal of Epilepsy Research · doi:10.14581/jer.19002 · Cited by 85
Tolerability of Antiseizure Medications in Individuals With Newly Diagnosed Epilepsy
Alsfouk, B. A. A., Brodie, M. J., Walters, J., Kwan, P., & Chen, Z. Z. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.0032 · Cited by 85
Self-citationLöscher, W., & White, H. S. (2023) · Cells · doi:10.3390/cells12091233 · Cited by 86
“An important characteristic of DRE is that most patients with DRE are resistant to several mechanistically distinct ASMs [9,10,14,16].”
BackgroundMitochondrial dysfunction and neurological disorders: A narrative review and treatment overview
Alshial, E. E., Abdulghaney, M. I., Wadan, A. S., Abdellatif, M. A., Ramadan, N. E., Suleiman, A. M., Waheed, N., Abdellatif, M., & Mohammed, H. S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122257 · Cited by 91
Treatment in canine epilepsy – a systematic review
Charalambous, M., Brodbelt, D. C., & Volk, H. A. (2014) · BMC Veterinary Research · doi:10.1186/s12917-014-0257-9 · Cited by 85
Antiepileptic drug combinations—Have newer agents altered clinical outcomes?
Stephen, L. J., Forsyth, M. G., Kelly, K., & Brodie, M. J. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.09.008 · Cited by 85
Self-citationFunctional network alterations and their structural substrate in drug-resistant epilepsy
Caciagli, L., Bernhardt, B. C., Hong, S., Bernasconi, A., & Bernasconi, N. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00411 · Cited by 84
Laser Interstitial Thermal Therapy for Mesial Temporal Lobe Epilepsy
Wicks, R. T., Jermakowicz, W. J., Jagid, J. R., Couture, D. E., Willie, J. T., Laxton, A. W., & Gross, R. E. (2016) · Neurosurgery · doi:10.1227/neu.0000000000001439 · Cited by 85
Current drug treatment of epilepsy in adults
McCorry, D., Chadwick, D. W., & Marson, A. G. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00935-4 · Cited by 85
Impact of epilepsy surgery on seizure control and quality of life: A 26‐year follow‐up study
Mohammed, H., Kaufman, C. B., Limbrick, D. D., Steger-May, K., Grubb, R. L., Rothman, S. M., Weisenberg, J. L. Z., Munro, R., & Smyth, M. D. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2011.03398.x · Cited by 84
Dietary nutrition for neurological disease therapy: Current status and future directions
Mao, X., Yin, X., Guan, Q.-W., Xia, Q., Yang, N., Zhou, H., Liu, Z., & Jin, W. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107861 · Cited by 85
Perucca, E., & Kwan, P. (2005) · CNS Drugs · doi:10.2165/00023210-200519110-00001 · Cited by 84
Self-citationPharmacological outcomes in newly diagnosed epilepsy
Mohanraj, R., & Brodie, M. J. (2005) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2005.01.008 · Cited by 84
Self-citationTreatment of medically refractory seizures with responsive neurostimulation: 2 pediatric cases
Kokoszka, M. A., Panov, F. E., Vega‐Talbott, M. L., McGoldrick, P. E., Wolf, S. M., & Ghatan, S. (2018) · Journal of Neurosurgery Pediatrics · doi:10.3171/2017.10.peds17353 · Cited by 83
Antiepileptic drugs and suicidality
Britton, J. W. (2010) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s13225 · Cited by 84
Salmenpera, T. M., Symms, M. R., Rugg‐Gunn, F. J., Boulby, P. A., Free, S. L., Barker, G. J., Yousry, T. A., & Duncan, J. S. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.00918.x · Cited by 83
Mechanisms of action of antiepileptic drugs: the search for synergy
Stafstrom, C. E. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32833735b5 · Cited by 83
Minimally invasive surgical approaches for temporal lobe epilepsy
Chang, E. F., Englot, D. J., & Vadera, S. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.04.033 · Cited by 83
Emergent epileptiform activity in neural networks with weak excitatory synapses
van Drongelen, W., Lee, H. C., Hereld, M., Chen, Z., Elsen, F. P., & Stevens, R. L. (2005) · IEEE Transactions on Neural Systems and Rehabilitation Engineering · doi:10.1109/tnsre.2005.847387 · Cited by 83
Deep brain and cortical stimulation for epilepsy
Sprengers, M., Vonck, K. E. J., Carrette, E., Marson, A. G., & Boon, P. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008497.pub2 · Cited by 83
Hirsch, M., Hintz, M., Specht, A., & Schulze‐Bonhage, A. (2018) · Seizure · doi:10.1016/j.seizure.2018.07.017 · Cited by 82
ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches
Leandro, K., Bicker, J., Alves, G., Falcão, A. C., & Fortuna, A. C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.031 · Cited by 87
Wang, C., Sun, W., Zhang, J., Zhang, J., Guo, Q., Zhou, X., Fan, D., Liu, H., Qi, M., Gao, X., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00618-4 · Cited by 84
Villanueva, V., Gomáriz, E. L., López-Trigo, J., Palau, J., García, M. E. R., Villarroya, T., Bonet, M., & Santafé, C. (2012) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.11.026 · Cited by 82
Visweswari, G., Prasad, K. S., Chetan, P. S., Valluru, L., & Rajendra, W. (2010) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2010.01.002 · Cited by 82
Do we need any more new antiepileptic drugs?
Brodie, M. J. (2001) · Epilepsy Research · doi:10.1016/s0920-1211(01)00203-0 · Cited by 82
Self-citationFinnema, S. J., Toyonaga, T., Detyniecki, K., Chen, M., Dias, M., Wang, Q., Lin, S., Naganawa, M., Gallezot, J., Lu, Y., et al. (2020) · Epilepsia · doi:10.1111/epi.16653 · Cited by 78
Bondallaz, P., Boëx, C., Rossetti, A. O., Foletti, G. B., Spinelli, L., Vulliémoz, S., Seeck, M., & Pollo, C. (2013) · Seizure · doi:10.1016/j.seizure.2013.02.007 · Cited by 81
Topiramate add-on for drug-resistant partial epilepsy
Pulman, J., Jetté, N., Dykeman, J., Hemming, K., Hutton, J. L., & Marson, A. G. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001417.pub3 · Cited by 81
Gumnit, R. J., & Walczak, T. S. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.08701.x · Cited by 81
Galiana, G. L., Gauthier, A. C., & Mattson, R. H. (2017) · Drugs in R&D · doi:10.1007/s40268-017-0197-5 · Cited by 81
Łuszczki, J. J., & Czuczwar, S. J. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.05104.x · Cited by 81
Soper, C., Wicker, E., Kulick, C. V., N’Gouemo, P., & Forcelli, P. A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.12.012 · Cited by 80
Vagus nerve stimulation for drug-resistant epilepsy
Pérez‐Carbonell, L., Faulkner, H. J., Higgins, S. E., Koutroumanidis, M., & Leschziner, G. D. (2019) · Practical Neurology · doi:10.1136/practneurol-2019-002210 · Cited by 80
Reddy, D. S. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114237 · Cited by 102
“In these patients, non-responsiveness to each additional ASM further diminishes the probability of eventual treatment success (Kwan and Brodie, 2000; Reddy, 2010; Chen et al., 2018; Reddy, 2020).”
Timofeev, I., Grenier, F., & Steriade, M. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00523.2003 · Cited by 80
Antiepileptic drug nonadherence predicts pediatric epilepsy seizure outcomes
Modi, A. C., Wu, Y. P., Rausch, J. R., Peugh, J., & Glauser, T. A. (2014) · Neurology · doi:10.1212/wnl.0000000000001023 · Cited by 80
Frankel, W. N. (2009) · Trends in Genetics · doi:10.1016/j.tig.2009.07.001 · Cited by 80
Rosenfeld, W. E., Conry, J. A., Lagae, L. G., Rozentals, G., Yang, H., Fain, R., Williams, B., Kumar, D., Zhu, J., & Laurenza, A. (2015) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2015.02.008 · Cited by 79
Finding a better drug for epilepsy: Preclinical screening strategies and experimental trial design
Simonato, M., Löscher, W., Cole, A. J., Dudek, F. E., Engel, J., Kaminski, R. M., Loeb, J. A., Scharfman, H. E., Staley, K. J., Velı́šek, L., et al. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03541.x · Cited by 79
The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study
Khuluza, F., & Häfele-Abah, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212125 · Cited by 79
Verrotti, A., Tambucci, R., Francesco, L. D., Pavone, P., Iapadre, G., Altobelli, E., Matricardi, S., Farello, G., & Belcastro, V. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1707668 · Cited by 79
Whitebirch, A. C., LaFrancois, J. J., Jain, S. S., Leary, P., Santoro, B., Siegelbaum, S. A., & Scharfman, H. E. (2022) · Neuron · doi:10.1016/j.neuron.2022.07.020 · Cited by 81
Disparities in surgery among patients with intractable epilepsy in a universal health system
Burneo, J. G., Shariff, S. Z., Liu, K., Leonard, S., Saposnik, G., & Garg, A. X. (2015) · Neurology · doi:10.1212/wnl.0000000000002249 · Cited by 79
Seizure outcomes in nonresective epilepsy surgery: an update
Englot, D. J., Birk, H. S., & Chang, E. F. (2016) · Neurosurgical Review · doi:10.1007/s10143-016-0725-8 · Cited by 79
Lin, C., Updegraff, J. A., & Pakpour, A. H. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.05.030 · Cited by 79
The role for ketogenic diets in epilepsy and status epilepticus in adults
Williams, T. J., & Cervenka, M. C. (2017) · Clinical Neurophysiology Practice · doi:10.1016/j.cnp.2017.06.001 · Cited by 79
Voltage-gated sodium channel β subunits: The power outside the pore in brain development and disease
Hull, J. M., & Isom, L. L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.09.018 · Cited by 79
New‐onset epilepsy in the elderly
Vu, L. C., Piccenna, L. G., Kwan, P., & O'Brien, T. J. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13653 · Cited by 79
Self-citationEffect of levetiracetam in refractory childhood epilepsy syndromes
Lagae, L. G., Buyse, G., Deconinck, A., & Ceulemans, B. (2003) · European Journal of Paediatric Neurology · doi:10.1016/s1090-3798(03)00041-2 · Cited by 79
Smith, M., Politzer, N., MacGarvie, D., McAndrews, M. P., & del Campo, M. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02941.x · Cited by 78
Do Antiepileptic Drugs Play a Role in Sudden Unexpected Death in Epilepsy?
Walczak, T. S. (2003) · Drug Safety · doi:10.2165/00002018-200326100-00001 · Cited by 78
Deep brain stimulation in epilepsy: what is next?
Kahane, P., & Depaulis, A. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283374a39 · Cited by 78
Kluger, G. J., Kurlemann, G., Haberlandt, E., Ernst, J., Runge, U., Schneider, F., Makowski, C. C., Boor, R., & Bast, T. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.12.013 · Cited by 78
Kellinghaus, C. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s5189 · Cited by 78
Does Resection of the Medial Temporal Lobe Improve the Outcome of Temporal Lobe Epilepsy Surgery?
Bonilha, L., Yasuda, C. L., Rorden, C., Li, L. M., Tedeschi, H., de OLIVEIRA, E., & Cendes, F. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2006.00958.x · Cited by 78
Jain, S. V., & Kothare, S. V. (2015) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2015.03.005 · Cited by 78
Rodrigues, A. D., Scheffel, T. B., Scola, G., dos Santos, M. T., Fank, B., de Freitas, S. C. V., Dani, C., Vanderlinde, R., Henriques, J. A. P., Coitinho, A. S., et al. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.01.009 · Cited by 78
Antiepileptic Drug Treatment of Epilepsy in Children
Moosa, A. N. V. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000712 · Cited by 79
Update on pharmacogenetics in epilepsy: a brief review
Szoeke, C. E. I., Newton, M. R., Wood, J. M., Goldstein, D. B., Berkovic, S. F., OBrien, T. J., & Sheffield, L. J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70352-0 · Cited by 78
Novel Medications for Epilepsy
Fattore, C., & Perucca, E. (2011) · Drugs · doi:10.2165/11594640-000000000-00000 · Cited by 75
Paschal, A. M., Rush, S. E., & Sadler, T. L. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.10.002 · Cited by 77
Sudden unexpected death in epilepsy: basic mechanisms and clinical implications for prevention
Dlouhy, B. J., Gehlbach, B. K., & Richerson, G. B. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-307442 · Cited by 78
Badawy, R. A. B., Jackson, G. D., Berkovic, S. F., & Macdonell, R. A. L. (2012) · International Journal of Neural Systems · doi:10.1142/s012906571250030x · Cited by 77
Nakhutina, L., Gonzalez, J. S., Margolis, S. A., Spada, A. H., & Grant, A. C. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.08.007 · Cited by 77
Outcomes of newly diagnosed idiopathic generalized epilepsy syndromes in a non-pediatric setting
Mohanraj, R., & Brodie, M. J. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00791.x · Cited by 77
Self-citationSpecific adverse effects of antiepileptic drugs — A true-to-life monotherapy study
Kowski, A. B., Weissinger, F., Gaus, V., Fidzinski, P., Losch, F., & Holtkamp, M. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.11.009 · Cited by 77
Pharmacodynamic interactions of antiepileptic drugs: From bench to clinical practice
Verrotti, A., Lattanzi, S., Brigo, F., & Zaccara, G. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.106939 · Cited by 82
Putting it all together: Options for intractable epilepsy
Benbadis, S. R., Geller, E. B., Ryvlin, P., Schachter, S. C., Wheless, J. W., Doyle, W., & Vale, F. Ĺ. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.05.030 · Cited by 76
Epigenetic mechanisms of neurodegenerative diseases and acute brain injury
Bertogliat, M. J., Morris-Blanco, K. C., & Vemuganti, R. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104642 · Cited by 83
Yang, H., Shi, W., Fan, J., Wang, T., Song, Y., Lian, Y., Shan, W., & Wang, Q. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01353-9 · Cited by 76
“However, approximately one third of the patients are not able to achieve seizure freedom despite appropriate medications and advent of new anti-seizure medications (ASMs), which is known as drug-resistant epilepsy [3].”
BackgroundSurgical versus medical treatment for refractory epilepsy: Outcomes beyond seizure control
Perry, M. S., & DUCHOWNY, M. S. (2013) · Epilepsia · doi:10.1111/epi.12427 · Cited by 76
No Pharmacokinetic Interaction Between Lacosamide and Carbamazepine in Healthy Volunteers
Cawello, W., Nickel, B., & Eggert‐Formella, A. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009347675 · Cited by 76
Non-invasive imaging of epileptic seizuresin vivousing photoacoustic tomography
Zhang, Q., Liu, Z., Carney, P. R., Yuan, Z., Chen, H., Roper, S. N., & Jiang, H. (2008) · Physics in Medicine and Biology · doi:10.1088/0031-9155/53/7/008 · Cited by 76
Łuszczki, J. J., Ratnaraj, N., Patsalos, P. N., & Czuczwar, S. J. (2006) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-006-0055-4 · Cited by 76
Synthesis of some novel N4-(naphtha[1,2-d]thiazol-2-yl)semicarbazides as potential anticonvulsants
Azam, F., Alkskas, I. A., Khokra, S. L., & Prakash, O. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.02.007 · Cited by 76
Muñana, K. R., Thomas, W., Inzana, K. D., Nettifee, J. A., McLucas, K., Olby, N. J., Mariani, C. L., & Early, P. J. (2012) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2011.00866.x · Cited by 76
Zuo, R., Jing, W., Li, X., Li, C., Zhao, C., Ren, Z., Liang, Y., Geng, X., Jiang, C., Yang, X., et al. (2019) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2019.00006 · Cited by 79
[11C]UCB-A, a novel PET tracer for synaptic vesicle protein 2A
Estrada, S., Lubberink, M., Thibblin, A., Sprycha, M., Buchanan, T., Mestdagh, N., Kenda, B., Mercier, J., Provins, L., Gillard, M., et al. (2016) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2016.03.004 · Cited by 71
Deep Brain Stimulation: Technology at the Cutting Edge
Shah, R. S., Chang, S.-Y., Min, H.-K. P., Cho, Z., Blaha, C. D., & Lee, K. H. (2010) · Journal of Clinical Neurology · doi:10.3988/jcn.2010.6.4.167 · Cited by 78
The Microbiota–Gut–Brain Axis and Epilepsy
Yue, Q., Cai, M., Xiao, B., Zhan, Q., & Zeng, C. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01130-2 · Cited by 80
Synthesis of isatin semicarbazones as novel anticonvulsants--role of hydrogen bonding.
Pandeya, S. N., Raja, A. S., & Stables, J. P. (2002) · PubMed · Cited by 75
Structural Consequences of Kcna1 Gene Deletion and Transfer in the Mouse Hippocampus
Wenzel, H. J., Vacher, H., Clark, E., Trimmer, J. S., Lee, A. L., Sapolsky, R. M., Tempel, B. L., & Schwartzkroin, P. A. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01189.x · Cited by 75
Treatment Options in Juvenile Myoclonic Epilepsy
Ritter, L. M., & Walker, M. C. (2011) · Current Treatment Options in Neurology · doi:10.1007/s11940-011-0131-z · Cited by 75
Localization-related epilepsy exhibits significant connectivity away from the seizure-onset area
Zaveri, H. P., Pincus, S. M., Goncharova, I. I., Duckrow, R. B., Spencer, D. D., & Spencer, S. S. (2009) · Neuroreport · doi:10.1097/wnr.0b013e32832c78e0 · Cited by 75
New GABA-modulating 1,2,4-oxadiazole derivatives and their anticonvulsant activity
Lankau, H., Unverferth, K., Grunwald, C., Hartenhauer, H., Heinecke, K., Bernöster, K., Dost, R., Egerland, U., & Rundfeldt, C. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.12.022 · Cited by 75
Precision medicine in genetic epilepsies: break of dawn?
Reif, P. S., Tsai, M., Helbig, I., Rosenow, F., & Klein, K. M. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1253476 · Cited by 77
Łuszczki, J. J., Czuczwar, M., Kiś, J., Krysa, J., Pasztelan, I., Świąder, M., & Czuczwar, S. J. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.10003.x · Cited by 75
Kumar, A., Asano, E., & Chugani, H. T. (2011) · Biomarkers in Medicine · doi:10.2217/bmm.11.68 · Cited by 76
Chromanone-A Prerogative Therapeutic Scaffold: An Overview
Kamboj, S., & Singh, R. (2021) · Arabian Journal for Science and Engineering · doi:10.1007/s13369-021-05858-3 · Cited by 76
Guidelines for Specialized Epilepsy Centers
Lado, F. A., Ahrens, S. M., Riker, E., Muh, C. R., Richardson, R. M., Gray, J. M., Small, B., Lewis, S. Z., Schofield, T. J., Clarke, D., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000208087 · Cited by 74
Metadata
- Authors
- Kwan, P., & Brodie, M. J.
- Affiliations
- Western Infirmary (GB)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2000-02-03
- Volume
- 342
- Issue
- 5
- Pages
- 314-319
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1974809694
- Cited by
- 5,204
- References
- 39
- Citations by year
- 2026: 225 · 2025: 241 · 2024: 259 · 2023: 275 · 2022: 269 · 2021: 328 · 2020: 348 · 2019: 253 · 2018: 270 · 2017: 228 · 2016: 249 · 2015: 230 · 2014: 205 · 2013: 233 · 2012: 248
- FWCI
- 55.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- CRC Press eBooks (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Keywords
- drug-resistant epilepsy, antiepileptic drugs, seizure control, newly diagnosed epilepsy, idiopathic epilepsy, symptomatic epilepsy, cryptogenic epilepsy, seizure frequency, predictors of treatment failure, adverse drug reactions, polypharmacy
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Anticonvulsants, Child, Epilepsy, Female, Humans, Male, Middle Aged, Prospective Studies, Remission Induction, Treatment Failure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review